Table 1 PI and NRTI Resistance Mutations Observed Between Weeks 24 and 108 in Patients Experiencing Virologic Failure in the M98-863 Study[2]
From: Genetic Barriers to Resistance and Impact on Clinical Response
| Regimen | PI resistance | 3TC resistance | d4T resistance |
|---|---|---|---|
| LPV/r + d4T + 3TC(N = 326) | 0/51 (0%) | 19/51 (37%) | 0/50 (0%)* |
| NFV + d4T + 3TC(N = 327) | 43/96 (45%) | 79/96 (82%) | 9/96 (9%) |